companydata.dkcompanydata.dk

Solid Therapeutics ApS: Financial statements 2025

CVR: 43007068

Source: annual report 2025, Danish Business Authority

01/01/202531/12/2025

Solid Therapeutics ApS (CVR 43007068) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -1,687,751 and a net result of DKK -4,355,625 compared with DKK -6,758,207 the year before. Equity in the 2025 report amounted to DKK -15,353,766. The company had 3 employees in the financial year.

Gross Profit
DKK -1,687,751
Profit/Loss
DKK -4,355,625
Equity
DKK -15,353,766
Total Assets
DKK 6,842,364
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--1.7 mio.-4.4 mio.-15.4 mio.3
2024--4.2 mio.-6.8 mio.-11 mio.4
2023--2.7 mio.-3.5 mio.-4.2 mio.2
2022--398 t.-797 t.-757 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Solid Therapeutics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

John Sørensen Haurum joins Solid Therapeutics ApS as adm. dir.Aug 28, 2025

As of August 28, 2025, John Sørensen Haurum is registered as adm. dir. of Solid Therapeutics ApS.

Anne Mette Hyldgaard Trauelsen steps down as adm. dir. of Solid Therapeutics ApSAug 28, 2025

As of August 28, 2025, Anne Mette Hyldgaard Trauelsen has stepped down as adm. dir. of Solid Therapeutics ApS.

Solid Therapeutics ApS: The 2024 annual report is outJun 26, 2025

Solid Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -4,213,656, and the net result was DKK -6,758,207.

About Solid Therapeutics ApS

Solid Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of John Sørensen Haurum. The company's owners include John Sørensen Haurum, Stine Helene Falsig Petersen and Anne Mette Hyldgaard Trauelsen. In 2025, the company reported a gross profit of DKK -1,687,751 and a net result of DKK -4,355,625 compared with DKK -6,758,207 the year before. Equity in the 2025 report amounted to DKK -15,353,766.

Source: annual report 2025, Danish Business Authority

Other financial years